Debt-to-equity of Vanda Pharmaceuticals Inc. from 31 Mar 2012 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Vanda Pharmaceuticals Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2012 to 30 Sep 2025.
  • Vanda Pharmaceuticals Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 26%, a 31% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Vanda Pharmaceuticals Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 26% +6% +31% 30 Sep 2025
Q2 2025 23% +4% +20% 30 Jun 2025
Q1 2025 21% +2% +11% 31 Mar 2025
Q4 2024 20% +1% +6.3% 31 Dec 2024
Q3 2024 20% 0% +0.88% 30 Sep 2024
Q2 2024 19% -1% -3.6% 30 Jun 2024
Q1 2024 19% -1% -6.2% 31 Mar 2024
Q4 2023 19% -1% -5.7% 31 Dec 2023
Q3 2023 19% 0% -0.77% 30 Sep 2023
Q2 2023 20% +1% +6.5% 30 Jun 2023
Q1 2023 20% +2% +10% 31 Mar 2023
Q4 2022 20% +3% +17% 31 Dec 2022
Q3 2022 20% +2% +13% 30 Sep 2022
Q2 2022 19% +2% +9% 30 Jun 2022
Q1 2022 18% +1% +7.3% 31 Mar 2022
Q4 2021 17% 0% -0.34% 31 Dec 2021
Q3 2021 17% 0% -0.23% 30 Sep 2021
Q2 2021 17% 0% -2.5% 30 Jun 2021
Q1 2021 17% -2% -12% 31 Mar 2021
Q4 2020 17% -4% -18% 31 Dec 2020
Q3 2020 17% -5% -22% 30 Sep 2020
Q2 2020 18% -5% -23% 30 Jun 2020
Q1 2020 19% -2% -11% 31 Mar 2020
Q4 2019 21% -2% -6.9% 31 Dec 2019
Q3 2019 22% -6% -22% 30 Sep 2019
Q2 2019 23% -14% -37% 30 Jun 2019
Q1 2019 22% -26% -55% 31 Mar 2019
Q4 2018 23% -36% -61% 31 Dec 2018
Q3 2018 29% -31% -52% 30 Sep 2018
Q2 2018 37% -24% -39% 30 Jun 2018
Q1 2018 48% -14% -22% 31 Mar 2018
Q4 2017 59% -5% -8.3% 31 Dec 2017
Q3 2017 59% -4% -6.8% 30 Sep 2017
Q2 2017 60% 0% -0.79% 30 Jun 2017
Q1 2017 62% +5% +9.2% 31 Mar 2017
Q4 2016 64% +14% +28% 31 Dec 2016
Q3 2016 64% +28% +76% 30 Sep 2016
Q2 2016 61% +13% +26% 30 Jun 2016
Q1 2016 57% -18% -24% 31 Mar 2016
Q4 2015 50% -99% -67% 31 Dec 2015
Q3 2015 36% -505% -93% 30 Sep 2015
Q2 2015 48% -288% -86% 30 Jun 2015
Q1 2015 75% -272% -78% 31 Mar 2015
Q4 2014 149% -262% -64% 31 Dec 2014
Q3 2014 541% -105% -16% 30 Sep 2014
Q2 2014 336% -999% -75% 30 Jun 2014
Q1 2014 346% -656% -65% 31 Mar 2014
Q4 2013 412% -344% -46% 31 Dec 2013
Q3 2013 646% +51% +8.6% 30 Sep 2013
Q2 2013 1334% +832% +166% 30 Jun 2013
Q1 2013 1002% +554% +124% 31 Mar 2013
Q4 2012 756% 31 Dec 2012
Q3 2012 595% 30 Sep 2012
Q2 2012 502% 30 Jun 2012
Q1 2012 448% 31 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.